Dabur Pharma gains on value buying

print   ·  

The Re 1-face valued Dabur Pharma stock, has been gaining steadily since April 1, with moderate volumes these days, thanks to investors who are said to be finally latching on to it after the company was carved out of FMCG major Dabur.

Dabur Pharma, in which IFC Washington holds over 7 per cent, is now believed to be coming up on its own. It closed at Rs 61.80 on the NSE, a level that is marginally lower than its recent high of over Rs 65.

Nilanjan Dey

(This article was published in the Business Line print edition dated May 6, 2006)
XThese are links to The Hindu Business Line suggested by Outbrain, which may or may not be relevant to the other content on this page. You can read Outbrain's privacy and cookie policy here.



Recent Article in MARKETS

FTIL shares jump 13% as it files for settlement with NSEL

While firm’s board approves the move, brokers’ forum terms offer an ‘eyewash’ »

Comments to: Copyright © 2015, The Hindu Business Line.